&w=3840&q=100)
Illinois Tech's Mumbai campus opening aims for 300-student inaugural batch
premium
Sanket Koul Shreya Nandi New Delhi
Listen to This Article
US-based Illinois Institute of Technology (Illinois Tech) is beginning preparations for opening its Mumbai campus in fall next year with an initial intake of around 300 students, Raj Echambadi, president, Illinois Tech, told Business Standard in a video interview.
'The institute is expecting to begin site exploration, and recruitment of faculty and staff in the next two-to-three months, so that active recruitment of students can start for an intake in the next fall,' Echambadi added.
Likening its upcoming Mumbai campus to a node in Illinois Tech's overall network, he said that many American students will get opportunities to study in
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
10 minutes ago
- Time of India
Qualcomm localising module production in India, supporting partners' manufacturing plans
US-based chip major Qualcomm is localising automotive module production in India and is supporting its top-tier ecosystem partners in their plan to move manufacturing into the country, a senior company official has said. Qualcomm Technologies, group general manager for automotive, industrial and embedded IoT, Nakul Duggal, told PTI that the company is investing heavily in India to support local automotive companies. "We build a lot of modules. Those modules are typically built in Taiwan, or China, or Korea, but we are now actively working in India to localise this. We, of course, partner with our Tier 1 ecosystem, such that as they move their manufacturing to India, we have been supporting them," he said. Duggal said that Qualcomm is a fabless company, which means it designs the chips but doesn't manufacture them. "For us, it's really about being able to create opportunities in our supply chain to be able to direct that (manufacture)," he said. Qualcomm has approximately 22,000 employees, or 60 per cent of its workforce, in India. Duggal said that the company has a local team to support domestic car manufacturers. Qualcomm has been bullish on chipsets for automobiles , especially electric vehicles . The company has partnered with all the major car OEMs (original equipment manufacturers), including Tata Motors, Mahindra, Maruti Suzuki and Hyundai, to provide them with chipsets for modernising cars. It has the Snapdragon Elite chipset platform for telematics, infotainment and driver assistance, including ADAS (Advanced Driver Assistance Systems). Duggal said that in 2026, there will probably be a dozen vehicles that will deploy its Snapdragon Cockpit Elite and Snapdragon Ride Elite SoC (System on Chip), which were announced in October 2024 and delivered to customers in early 2025. He said that India has a substantial domestic footprint encompassing both domestic and global automakers that manufacture locally. "There is a huge need for building products that cater to the needs of the Indian region. Rather than bringing in a product that is built for a global customer, build a product for a local customer. That necessitates for an OEM the need to have engineering capability, creative capability, to actually think about the needs of the local region, and we are starting to see that happen," he said. Duggal said building an automotive product for the local market will generate a competitive advantage, and China has benefited from this trend. The automotive segment of the company accounts for around 10 per cent of its global revenue, which is around USD 3.6 billion to USD 3.8 billion. The company has set a target to double the total revenue from the automotive business to about USD 8 billion by 2029.
&w=3840&q=100)
Business Standard
10 minutes ago
- Business Standard
NSDL Q1 results: Net profit rises 24% to ₹82 crore on higher revenue
Total income climbed 21.68 per cent to Rs 190.4 crore in the quarter under review from Rs 156.5 crore in April-June FY25, the newly-listed company said in a statement Press Trust of India New Delhi National Securities Depository Ltd (NSDL) on Tuesday posted 24 per cent rise in net profit at Rs 82.6 crore for June quarter 2025-26 driven by strong revenue growth and expansion in market share. In the same quarter last year, the depository had logged a profit of of Rs 66.6 crore. Total income climbed 21.68 per cent to Rs 190.4 crore in the quarter under review from Rs 156.5 crore in April-June FY25, the newly-listed company said in a statement. Operationally, NSDL's demat account market share surged to 15.5 per cent from 9.4 per cent a year ago, with the total number of demat accounts crossing the 4-crore mark as of June 30, 2025. In the unlisted market segment, the number of companies admitted rose to 10,392 during the quarter, taking the depository's equity market share to 73.2 per cent, up from 70.8 per cent in Q1 FY25. NSDL, which debuted in the market on August 6, also retained a dominant 86.6 per cent share of total demat custody value. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
&w=3840&q=100)
Business Standard
10 minutes ago
- Business Standard
Alkem Labs Q1 profit rises 22% to ₹664 cr on India, overseas sales growth
Alkem Laboratories on Tuesday reported a 22 per cent year-on-year (Y-o-Y) rise in its consolidated net profit for the June quarter (Q1FY26) to ₹664.3 crore, up from ₹545.2 crore in the same period last year. Revenue from operations increased 11.2 per cent Y-o-Y to ₹3,371 crore in Q1FY26 from ₹3,031 crore in Q1FY25. The company attributed this growth to strong sales in both India and international markets. Commenting on the performance, Vikas Gupta, Chief Executive Officer of Alkem, said Q1FY26 marked a strong start to the year, with healthy growth across both domestic and overseas markets. India sales grew 12 per cent Y-o-Y to ₹2,265 crore in the June quarter, while international sales rose 8.9 per cent to ₹1,054 crore, contributing 31.7 per cent to overall revenue. In the international business, the United States market recorded sales of ₹698 crore, up 8.8 per cent from ₹641.6 crore a year earlier, contributing 21 per cent to total sales. Sales from other international markets — including Latin America, Australia, and Europe — rose 9.1 per cent to ₹355.6 crore, contributing 10.7 per cent to revenue. Gupta said the company is strategically accelerating its focus on the non-US business segment by strengthening its presence in high-potential markets and capturing new opportunities aligned with Alkem's long-term growth ambitions. Alkem also announced it will incorporate a Saudi Arabia-based subsidiary, holding a 51 per cent stake. 'The subsidiary is proposed to be incorporated as a limited liability company and will be involved in the manufacture, import, marketing, and distribution of pharmaceutical and/or nutraceutical products within the Kingdom of Saudi Arabia,' the company said in a filing to the exchanges. On Tuesday, Alkem Laboratories' share price rose 6.7 per cent to close at ₹5,167 on the Bombay Stock Exchange (BSE).
